Home
Stoke Therapeutics

Stoke Therapeutics Market Share Analysis for August 2026

Isabel Aznarez has extensive experience in human genetics, RNA metabolism and modulation of RNA processes using antisense oligonucleotides.

Health > Biotechnology and Pharmaceuticals

Domainstoketherapeutics.com

Year Founded2014

Employees51 - 200

Annual Revenue$100M - $200M

Stoke Therapeutics

Stoke Therapeutics (including company regionals)

stoketherapeutics.com

See more website traffic and engagement information

Stoke Therapeutics Revenue up to August 2026 is 100M - 200M

revenue generated by Stoke Therapeutics top domains

Stoke Therapeutics top domains revenue over 3 years

Revenue for Stoke Therapeutics top domains

stoketherapeutics.com100M - 200M

See more with Sales Intelligence

Total visits to Stoke Therapeutics's top domains

Understand Stoke Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

stoketherapeutics.com14.7K

See more with Sales Intelligence

Avg. visit duration in Stoke Therapeutics's top domains

Analyze Stoke Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

stoketherapeutics.com00:01:11

See more with Sales Intelligence

Avg. pageviews on Stoke Therapeutics's top domains

See how Stoke Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

stoketherapeutics.com2.02

See more with Sales Intelligence

Stoke Therapeutics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

maxcyte.comCompany NameMaxCyteEmployees51 - 200HQUnited States, Maryland, GaithersburgAnnual revenue$25M - $50MTotal visits12.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Stoke Therapeutics

These are the website technologies, by industry, used by Stoke Therapeutics top domains

Payment & Currencies (8)

Cart Functionality

Content Management System (4)

WordPress

Conversion & Analytics (4)

Google Analytics

Widget (4)

Twemoji

More Technologies

11

See all

News & Signals from Stoke Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsStoke Therapeutics attended event 16th European Epilepsy Congress on Sep 5th '26.Stoke Therapeutics (NASDAQ:STOK) and Biogen (NASDAQ:BIIB) said they will present clinical data for zorevunersen, their investigational treatment for Dravet syndrome, at the 16th European Epilepsy Congress in Athens, Greece, from September 5 to 9.

NewsStoke Therapeutics had revenue of $9.32M on Aug 5th '26.* Mixed quarterly results: Stoke reported $9.32 million in revenue, well above the $4.89 million consensus estimate, but its $0.93 quarterly loss per share was wider than expected.

NewsStoke Therapeutics received award 2026 Catalyst for Change Award on Jul 1st '26.The 2026 Catalyst for Change Award was proudly presented to Stoke Therapeutics in recognition of its outstanding contributions to the field of Dravet syndrome.